Direct to Consumer Predictive Genomic Testing & Risk Perception

submitted by: mcgheekkm
Dr. Clayton Cowl, Associate Professor of Medicine from the Division of Preventive, Occupational, and Aerospace Medicine at Mayo Clinic in Rochester, MN, discusses his article appearing in the October 2011 issue of Mayo Clinic Proceedings which compares risk perception and worry between patient groups receiving routine care and predictive genetic testing. Available at: http://www.mayoclinicproceedings.com/content/86/10/933.abstract

Rabbit Models for Alzheimer's Disease

submitted by: alex01

Diana Woodruff-Pak (Temple University, Philadelphia, PA) used cholesterol-fed rabbits as a model of AD for evaluation of currently available and potential anti-Alzheimer drugs. These animals developed typical Alzheimer pathology, including behavioral changes and deposition of ß-amyloid and even
tau. Galantamine and donepezil partially protected animals from Alzheimer symptomatology.